Across TCGA pan-cancer cohorts, CDCA4P2 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of CDCA4P2’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where CDCA4P2 RNA is repressed in tumor relative to normal tissue. In most cancer types CDCA4P2 is over-expressed in tumor, although a few such as HNSC and COAD show the opposite, repressed pattern.

HNSC, COAD, and BLCA are the cancer types where CDCA4P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CDCA4P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	II,III,IV	−0.103	<.001	8	view →
COAD	Male	All	−0.297	<.001	5	view →
BLCA	Female	III,IV	−0.381	.007	4	view →
READ	All	All	−0.327	.004	2	view →
LUSC	Male	All	+0.018	.033	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: CDCA4P2 RNA expression & survival · all CDCA4P2 data types